Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

EMCCD Camera

By Drug Discovery Trends Editor | October 19, 2012

Photometrics introduces its Evolve 512 Delta EMCCD camera. The Evolve 512 Delta possesses fast frame rates and high sensitivity for a camera of its class, enabling researchers to obtain high quality super-resolution images in half the time it takes other 512×512 EMCCD cameras on the market.

For super-resolution experiments to be successful, researchers need a camera capable of collecting data at extremely high frame rates. While the optical components for super-resolution imaging have improved, camera technology remains limited by its speed, creating a bottleneck. Equipped with a sensor running at 20MHz that captures images at 62.5 frames per second and read noise <1e- (using EM gain), the Evolve 512 Delta makes super-resolution imaging much more productive and efficient.

The Evolve 512 Delta was specifically designed for super-resolution applications such as STORM, PALM and GSD. The camera is also suited for a range of other applications including SMF and tracking, live-cell spinning disk confocal, SPIM, intrinsic imaging, FCWS, TIRF, FRET, and FRAP.

Evolve 512 Delta is the only camera to offer these features and benefits:

• 20 MHz sensor
• 62.5 frames per second
• >90% quantum efficiency
• Quantitative performance

“Photometrics recognizes the increasing demands for life science research facilities to achieve faster results with limited resources,” said Rachit Mohindra, Photometrics product manager. “The Evolve 512 Delta brings those benefits to researchers working in super-resolution and other demanding applications.”

Photometrics is providing existing Evolve 512 customers with an option to upgrade their legacy cameras to the performance level of the Evolve 512 Delta, extending the life of their investment. The upgrade package will be available through the company’s global service centers.

Photometrics


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50